Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jun 18;11(6):844.
doi: 10.3390/cancers11060844.

PTEN Hamartoma Tumor Syndrome: A Clinical Overview

Robert Pilarski  1
Affiliations
Review

PTEN Hamartoma Tumor Syndrome: A Clinical Overview

Robert Pilarski. Cancers (Basel). .

Abstract

The phosphatase and tensin homolog (PTEN) hamartoma tumor syndrome (PHTS) is a grouping of related genetic disorders that has been linked to germline mutations in the PTEN gene. These disorders include Cowden syndrome (CS), Bannayan-Riley-Ruvalcaba syndrome, adult Lhermitte-Duclos disease, and autism spectrum disorders associated with macrocephaly. The majority of the clinical information available on PHTS, however, is related to individuals diagnosed with CS. There is still much to be learned about this disorder, since diagnostic criteria for CS were only established in 1996, before the identification of the PTEN gene, and were based primarily on features seen in cases reported in the existing literature. More recently, however, data from several large series of patients have shown that a number of the clinical features associated with PTEN mutations are either more or less common than previously reported. In addition, we now know that only about 30-35% of patients meeting clinical diagnostic criteria for Cowden syndrome actually have a detectable PTEN mutation. Thus, our understanding of PTEN-related diseases and their management has evolved significantly over time. The United States National Comprehensive Cancer Network (NCCN) has produced and regularly updates practice guidelines which include clinical diagnostic criteria as well as guidelines for PTEN testing and management of patients with mutations. This review will summarize the overall literature on PHTS as well as recent findings which are broadening our understanding of this set of disorders.

Keywords: Bannayan-Ruvalcaba-Riley syndrome; PHTS; PTEN; PTEN harmartoma tumor syndrome; cowden syndrome.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Lloyd K.M., Denis M. Cowden’s disease: A possible new symptom complex with multiple system involvement. Ann. Intern. Med. 1963;58:136–142. doi: 10.7326/0003-4819-58-1-136. - DOI - PubMed
    1. Nelen M.R., van Staveren C.G., Peeters E.A.J., Ben Hassel M., Gorlin R.J., Hamm H., Lindboe C.F., Fryns J.-P., Sijmons R.H., Woods D.G., et al. Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum. Mol. Genet. 1997;6:1383–1387. doi: 10.1093/hmg/6.8.1383. - DOI - PubMed
    1. Liaw D., Marsh D.J., Li J., Dahia P.L.M., Wang S.I., Zheng Z., Bose S., Call K.M., Tsou H.C., Peacocke M., et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet. 1997;16:64–67. doi: 10.1038/ng0597-64. - DOI - PubMed
    1. Gorlin R.J., Cohen M.M., Jr., Condon L.M., Burke B.A. Bannayan-Riley-Ruvalcaba syndrome. Am. J. Med. Genet. 1992;44:307–314. doi: 10.1002/ajmg.1320440309. - DOI - PubMed
    1. Marsh D.J., Kum J.B., Lunetta K.L., Bennett M.J., Gorlin R.J., Ahmed S.F., Bodurtha J., Crowe C., Curtis M.A., Dazouki M., et al. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum. Mol. Genet. 1999;8:1461–1472. doi: 10.1093/hmg/8.8.1461. - DOI - PubMed